Published in Am J Obstet Gynecol on July 01, 2005
Noninvasive uterine electromyography for prediction of preterm delivery. Am J Obstet Gynecol (2010) 2.03
Magnetomyographic recording and identification of uterine contractions using Hilbert-wavelet transforms. Physiol Meas (2009) 0.90
Use of uterine electromyography to diagnose term and preterm labor. Acta Obstet Gynecol Scand (2010) 0.90
Velocity and directionality of the electrohysterographic signal propagation. PLoS One (2014) 0.84
Tracking the changes in synchrony of the electrophysiological activity as the uterus approaches labor using magnetomyographic technique. Reprod Sci (2014) 0.84
Extraction, quantification and characterization of uterine magnetomyographic activity--a proof of concept case study. Eur J Obstet Gynecol Reprod Biol (2009) 0.83
Frequency-domain near-infrared spectroscopy of the uterine cervix during regular pregnancies. Lasers Med Sci (2010) 0.82
Women with high-risk pregnancies, problems, and APN interventions. J Nurs Scholarsh (2007) 0.80
Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status. Lasers Med Sci (2008) 0.77
Health Problems and APN Interventions in Pregnant Women with Diabetes. Pac Rim Int J Nurs Res Thail (2012) 0.76
Use of progesterone and progestin analogs for inhibition of preterm birth and other uterine contractility disorders. Facts Views Vis Obgyn (2012) 0.76
Modeling Magnetomyograms of Uterine Contractions during Pregnancy Using a Multiscale Forward Electromagnetic Approach. PLoS One (2016) 0.75
Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol (2006) 5.99
Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol (2012) 4.63
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med (2003) 4.04
Effectiveness of electronic fetal monitoring with additional ST analysis in vertex singleton pregnancies at >36 weeks of gestation: an individual participant data metaanalysis. Am J Obstet Gynecol (2013) 3.10
A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis. N Engl J Med (2015) 2.86
Impact of maternal age on obstetric outcome. Obstet Gynecol (2005) 2.60
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40
First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol (2007) 2.31
Antiphospholipid antibodies in stillbirth. Obstet Gynecol (2013) 2.04
Noninvasive uterine electromyography for prediction of preterm delivery. Am J Obstet Gynecol (2010) 2.03
Unjustified increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17α-hydroxyprogesterone caproate). Obstet Gynecol (2011) 2.01
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol (2009) 1.92
The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol (2007) 1.65
Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med (2012) 1.56
Hospital readmission after delivery: evidence for an increased incidence of nonurogenital infection in the immediate postpartum period. Am J Obstet Gynecol (2009) 1.54
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol (2011) 1.50
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol (2012) 1.49
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol (2009) 1.48
A randomized trial of amnioreduction versus septostomy in the treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol (2005) 1.48
A population-based case-control study of stillbirth: the relationship of significant life events to the racial disparity for African Americans. Am J Epidemiol (2013) 1.48
The fetal origins of hypertension: a systematic review and meta-analysis of the evidence from animal experiments of maternal undernutrition. J Hypertens (2012) 1.46
Contingent screening for Down syndrome--results from the FaSTER trial. Prenat Diagn (2008) 1.45
Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol (2006) 1.43
Effect of gestational age and position on peak expiratory flow rate: a longitudinal study. Obstet Gynecol (2005) 1.42
Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol (2008) 1.41
A suggested approach for implementing CONSORT guidelines specific to obstetric research. Obstet Gynecol (2013) 1.38
Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum. Am J Physiol Gastrointest Liver Physiol (2007) 1.35
Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatr Perinat Epidemiol (2011) 1.31
Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol (2010) 1.26
Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol (2007) 1.22
Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) (2007) 1.22
New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension (2013) 1.20
Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol (2012) 1.20
Physiology and electrical activity of uterine contractions. Semin Cell Dev Biol (2007) 1.15
Putting the "M" back in maternal-fetal medicine. Am J Obstet Gynecol (2012) 1.14
Late preterm birth: how often is it avoidable? Am J Obstet Gynecol (2009) 1.11
Cervical ripening and insufficiency: from biochemical and molecular studies to in vivo clinical examination. Eur J Obstet Gynecol Reprod Biol (2009) 1.07
Maternal mortality, near misses, and severe morbidity: lowering rates through designated levels of maternity care. Obstet Gynecol (2012) 1.07
Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PLoS Med (2006) 1.06
A new system for determining the causes of stillbirth. Obstet Gynecol (2010) 1.06
Characterization of abdominally acquired uterine electrical signals in humans, using a non-linear analytic method. Med Biol Eng Comput (2006) 1.06
Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Am J Obstet Gynecol (2011) 1.00
Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstet Gynecol (2011) 0.99
Association of zoonotic Ljungan virus with intrauterine fetal deaths. Birth Defects Res A Clin Mol Teratol (2007) 0.98
Sonographic myometrial thickness predicts the latency interval of women with preterm premature rupture of the membranes and oligohydramnios. Am J Obstet Gynecol (2005) 0.98
The effect of acculturation on progesterone/estriol ratios and preterm birth in Hispanics. Obstet Gynecol (2008) 0.97
Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol (2008) 0.97
Pregnancy as a window to future health. Obstet Gynecol (2009) 0.95
Characterization of a murine model of fetal programming of atherosclerosis. Am J Obstet Gynecol (2007) 0.95
An algorithm for the estimation of gestational age at the time of fetal death. Paediatr Perinat Epidemiol (2013) 0.94
Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix. J Histochem Cytochem (2006) 0.94
The effect of dystocia and previous cesarean uterine scar on the tensile properties of the lower uterine segment. Am J Obstet Gynecol (2006) 0.94
Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Reprod Sci (2013) 0.93
Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet Gynecol (2014) 0.93
Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol (2007) 0.93
Fetal origins of adult vascular dysfunction in mice lacking endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol (2004) 0.93
Uterine electromyography characteristics for early diagnosis of mifepristone-induced preterm labor. Obstet Gynecol (2005) 0.92
A Core Outcome Set for Evaluation of Interventions to Prevent Preterm Birth. Obstet Gynecol (2016) 0.91
Induction of premature labor and delivery by allergic reaction and prevention by histamine H1 receptor antagonist. Am J Obstet Gynecol (2004) 0.91
Identification of term and preterm labor in rats using artificial neural networks on uterine electromyography signals. Am J Obstet Gynecol (2008) 0.90
Use and misuse of the term "elective" in obstetrics. Obstet Gynecol (2011) 0.90
Use of uterine electromyography to diagnose term and preterm labor. Acta Obstet Gynecol Scand (2010) 0.90
Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol (2009) 0.90
Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. Am J Obstet Gynecol (2002) 0.89
Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost (2008) 0.89
Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Am J Physiol Heart Circ Physiol (2009) 0.89
Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle. Am J Obstet Gynecol (2010) 0.88
Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia. Am J Obstet Gynecol (2005) 0.88
Hemodynamic evaluation in pregnancy: limitations of impedance cardiography. Physiol Meas (2012) 0.87
Impact of array comparative genomic hybridization-derived information on genetic counseling demonstrated by prenatal diagnosis of the TAR (thrombocytopenia-absent-radius) syndrome-associated microdeletion 1q21.1. Am J Hum Genet (2007) 0.87
Degranulation of uterine mast cell modifies contractility of isolated myometrium from pregnant women. Am J Obstet Gynecol (2004) 0.87
First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol (2007) 0.86
Maternal hypercholesterolemia leads to activation of endogenous cholesterol synthesis in the offspring. Am J Obstet Gynecol (2008) 0.85
The effect of bilateral pelvic neurectomy on uterine and abdominal electrical and pressure activity, as measured by telemetry in conscious, unrestrained pregnant rats. J Perinat Med (2009) 0.85
Cervical light-induced fluorescence in humans decreases throughout gestation and before delivery: Preliminary observations. Am J Obstet Gynecol (2003) 0.85
The association of stillbirth with depressive symptoms 6-36 months post-delivery. Paediatr Perinat Epidemiol (2015) 0.85
Pregnancy complicated by cyclic vomiting syndrome. Obstet Gynecol (2009) 0.84
The role of massive transfusion protocols in obstetrics. Am J Perinatol (2012) 0.84
Amniotic fluid metabolomic analysis in spontaneous preterm birth. Reprod Sci (2014) 0.84
NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls. Acta Obstet Gynecol Scand (2009) 0.84
Impairment of fetal growth potential and neonatal encephalopathy. Am J Obstet Gynecol (2003) 0.84
IgE-independent mast cell activation augments contractility of nonpregnant and pregnant guinea pig myometrium. Int Arch Allergy Immunol (2008) 0.84
Approximately one-third of medically indicated late preterm births are complicated by fetal growth restriction. Am J Obstet Gynecol (2011) 0.84
Changes in haemodynamic and autonomous nervous system parameters measured non-invasively throughout normal pregnancy. Eur J Obstet Gynecol Reprod Biol (2009) 0.84
Increased uterine arterial pressure and contractility of perfused swine uterus after treatment with serum from pre-eclamptic women and endothelin-1. Clin Sci (Lond) (2005) 0.83
Transcranial doppler measurement of cerebral velocity indices as a predictor of preeclampsia. Am J Obstet Gynecol (2002) 0.83
Light-induced fluorescence of the human cervix decreases after prostaglandin application for induction of labor at term. Eur J Obstet Gynecol Reprod Biol (2005) 0.83
Expression of 8-oxoguanine glycosylase in human fetal membranes. Am J Reprod Immunol (2014) 0.83
Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol (2006) 0.83
A genome-wide association study of early spontaneous preterm delivery. Genet Epidemiol (2015) 0.83
The first cesarean: role of "fetal distress" diagnosis. Semin Perinatol (2012) 0.82
The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate. Am J Obstet Gynecol (2002) 0.82
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers. Am J Obstet Gynecol (2008) 0.82
The validity of cervical dilation as an indication of true labor between 32 and 36 weeks 6 days of gestation. Am J Obstet Gynecol (2007) 0.81
Use of uterine EMG and cervical LIF in monitoring pregnant patients. BJOG (2005) 0.81
Effects of recombinant human relaxin on pregnant rat uterine artery and myometrium in vitro. Am J Obstet Gynecol (2003) 0.81